Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients

Abstract Background Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disorder caused by mutations in the FLCN gene coding for folliculin. Its clinical expression includes cutaneous fibrofolliculomas, renal tumors, multiple pulmonary cysts, and recurrent spontaneous pneumothoraces. Data on...

Full description

Bibliographic Details
Main Authors: C. Daccord, V. Cottin, G. Prévot, Y. Uzunhan, J. F. Mornex, P. Bonniaud, R. Borie, A. Briault, M. A. Collonge-Rame, B. Crestani, G. Devouassoux, O. Freynet, A. Gondouin, P. A. Hauss, C. Khouatra, S. Leroy, S. Marchand-Adam, C. Marquette, D. Montani, J. M. Naccache, G. Nadeau, N. Poulalhon, M. Reynaud-Gaubert, M. Salaun, B. Wallaert, J. F. Cordier, M. Faouzi, R. Lazor, the OrphaLung network
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13023-020-01402-y
id doaj-466fe3960a5340c4bf1a5660c39919e7
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author C. Daccord
V. Cottin
G. Prévot
Y. Uzunhan
J. F. Mornex
P. Bonniaud
R. Borie
A. Briault
M. A. Collonge-Rame
B. Crestani
G. Devouassoux
O. Freynet
A. Gondouin
P. A. Hauss
C. Khouatra
S. Leroy
S. Marchand-Adam
C. Marquette
D. Montani
J. M. Naccache
G. Nadeau
N. Poulalhon
M. Reynaud-Gaubert
M. Salaun
B. Wallaert
J. F. Cordier
M. Faouzi
R. Lazor
the OrphaLung network
spellingShingle C. Daccord
V. Cottin
G. Prévot
Y. Uzunhan
J. F. Mornex
P. Bonniaud
R. Borie
A. Briault
M. A. Collonge-Rame
B. Crestani
G. Devouassoux
O. Freynet
A. Gondouin
P. A. Hauss
C. Khouatra
S. Leroy
S. Marchand-Adam
C. Marquette
D. Montani
J. M. Naccache
G. Nadeau
N. Poulalhon
M. Reynaud-Gaubert
M. Salaun
B. Wallaert
J. F. Cordier
M. Faouzi
R. Lazor
the OrphaLung network
Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients
Orphanet Journal of Rare Diseases
Birt-Hogg-Dube syndrome
FLCN protein, human
Respiratory function tests
Pleurodesis
author_facet C. Daccord
V. Cottin
G. Prévot
Y. Uzunhan
J. F. Mornex
P. Bonniaud
R. Borie
A. Briault
M. A. Collonge-Rame
B. Crestani
G. Devouassoux
O. Freynet
A. Gondouin
P. A. Hauss
C. Khouatra
S. Leroy
S. Marchand-Adam
C. Marquette
D. Montani
J. M. Naccache
G. Nadeau
N. Poulalhon
M. Reynaud-Gaubert
M. Salaun
B. Wallaert
J. F. Cordier
M. Faouzi
R. Lazor
the OrphaLung network
author_sort C. Daccord
title Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients
title_short Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients
title_full Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients
title_fullStr Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients
title_full_unstemmed Lung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patients
title_sort lung function in birt-hogg-dubé syndrome: a retrospective analysis of 96 patients
publisher BMC
series Orphanet Journal of Rare Diseases
issn 1750-1172
publishDate 2020-05-01
description Abstract Background Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disorder caused by mutations in the FLCN gene coding for folliculin. Its clinical expression includes cutaneous fibrofolliculomas, renal tumors, multiple pulmonary cysts, and recurrent spontaneous pneumothoraces. Data on lung function in BHD are scarce and it is not known whether lung function declines over time. We retrospectively assessed lung function at baseline and during follow-up in 96 patients with BHD. Results Ninety-five percent of BHD patients had multiple pulmonary cysts on computed tomography and 59% had experienced at least one pneumothorax. Mean values of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, and total lung capacity were normal at baseline. Mean (standard deviation) residual volume (RV) was moderately increased to 116 (36) %pred at baseline, and RV was elevated > 120%pred in 41% of cases. Mean (standard deviation) carbon monoxide transfer factor (DLco) was moderately decreased to 85 (18) %pred at baseline, and DLco was decreased < 80%pred in 33% of cases. When adjusted for age, gender, smoking and history of pleurodesis, lung function parameters did not significantly decline over a follow-up period of 6 years. Conclusions Cystic lung disease in BHD does not affect respiratory function at baseline except for slightly increased RV and reduced DLco. No significant deterioration of lung function occurs in BHD over a follow-up period of 6 years.
topic Birt-Hogg-Dube syndrome
FLCN protein, human
Respiratory function tests
Pleurodesis
url http://link.springer.com/article/10.1186/s13023-020-01402-y
work_keys_str_mv AT cdaccord lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT vcottin lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT gprevot lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT yuzunhan lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT jfmornex lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT pbonniaud lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT rborie lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT abriault lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT macollongerame lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT bcrestani lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT gdevouassoux lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT ofreynet lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT agondouin lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT pahauss lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT ckhouatra lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT sleroy lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT smarchandadam lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT cmarquette lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT dmontani lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT jmnaccache lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT gnadeau lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT npoulalhon lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT mreynaudgaubert lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT msalaun lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT bwallaert lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT jfcordier lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT mfaouzi lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT rlazor lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
AT theorphalungnetwork lungfunctioninbirthoggdubesyndromearetrospectiveanalysisof96patients
_version_ 1724507747458744320
spelling doaj-466fe3960a5340c4bf1a5660c39919e72020-11-25T03:46:07ZengBMCOrphanet Journal of Rare Diseases1750-11722020-05-011511810.1186/s13023-020-01402-yLung function in Birt-Hogg-Dubé syndrome: a retrospective analysis of 96 patientsC. Daccord0V. Cottin1G. Prévot2Y. Uzunhan3J. F. Mornex4P. Bonniaud5R. Borie6A. Briault7M. A. Collonge-Rame8B. Crestani9G. Devouassoux10O. Freynet11A. Gondouin12P. A. Hauss13C. Khouatra14S. Leroy15S. Marchand-Adam16C. Marquette17D. Montani18J. M. Naccache19G. Nadeau20N. Poulalhon21M. Reynaud-Gaubert22M. Salaun23B. Wallaert24J. F. Cordier25M. Faouzi26R. Lazor27the OrphaLung networkService de pneumologie, Centre hospitalier universitaire vaudois, Université de LausanneService de pneumologie, Centre national coordinateur de référence des maladies pulmonaires rares, hôpital Louis Pradel, Hospices Civils de Lyon, Université de Lyon, Université Claude Bernard Lyon 1Service de pneumologie, Centre hospitalier universitaire de ToulouseService de pneumologie, Assistance Publique Hôpitaux de Paris, Hôpital Avicenne, INSERM UMR 1272, Université Paris 13Service de pneumologie, Centre national coordinateur de référence des maladies pulmonaires rares, hôpital Louis Pradel, Hospices Civils de Lyon, Université de Lyon, Université Claude Bernard Lyon 1Service de Pneumologie et Soins Intensifs Respiratoires, Centre hospitalier universitaire Dijon/Bourgogne, Université Bourgogne-Franche Comté, INSERM U123-1Service de pneumologie, Assistance Publique Hôpitaux de Paris, Hôpital Bichat - Claude BernardService de pneumologie, Centre hospitalier universitaire de GrenobleService de génétique biologique - histologie, UF cytogénétique, UF consultations d’oncogénétique, Centre hospitalier universitaire de BesançonService de pneumologie, Assistance Publique Hôpitaux de Paris, Hôpital Bichat - Claude BernardService de pneumologie, Hospices Civils de Lyon, Hôpital de la Croix-RousseService de pneumologie, Assistance Publique Hôpitaux de Paris, Hôpital Avicenne, INSERM UMR 1272, Université Paris 13Service de pneumologie, Centre hospitalier universitaire de BesançonCentre hospitalier intercommunal Elbeuf - Louviers - Val de ReuilService de pneumologie, Centre national coordinateur de référence des maladies pulmonaires rares, hôpital Louis Pradel, Hospices Civils de Lyon, Université de Lyon, Université Claude Bernard Lyon 1Service de pneumologie, Université Côte d’Azur, Centre hospitalier universitaire de Nice, CNRS, INSERM, FHU OncoAgeService de pneumologie, Centre hospitalier universitaire de ToursService de pneumologie, Université Côte d’Azur, Centre hospitalier universitaire de Nice, CNRS, INSERM, FHU OncoAgeService de Pneumologie, Université Paris–Sud, Assistance Publique Hôpitaux de Paris, INSERM UMR S999, Hôpital de BicêtreService de Pneumologie, Site constitutif du Centre de référence des maladies pulmonaires rares OrphaLung, Assistance Publique Hôpitaux de Paris, Hôpital TenonCentre hospitalier Métropole Savoie, UF de Génétique chromosomiqueService de dermatologie, Hospices Civils de Lyon, Centre hospitalier Lyon-SudService de pneumologie, Centre de compétences des maladies pulmonaires rares, Assistance Publique Hôpitaux de Marseille, Centre hospitalier universitaire de Marseille, Aix Marseille UniversitéService de pneumologie, Centre hospitalier universitaire de RouenService de pneumologie, Centre hospitalier universitaire de LilleService de pneumologie, Centre national coordinateur de référence des maladies pulmonaires rares, hôpital Louis Pradel, Hospices Civils de Lyon, Université de Lyon, Université Claude Bernard Lyon 1Division de biostatistique, Centre universitaire de médecine générale et santé publique (Unisanté), Université de LausanneService de pneumologie, Centre hospitalier universitaire vaudois, Université de LausanneAbstract Background Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disorder caused by mutations in the FLCN gene coding for folliculin. Its clinical expression includes cutaneous fibrofolliculomas, renal tumors, multiple pulmonary cysts, and recurrent spontaneous pneumothoraces. Data on lung function in BHD are scarce and it is not known whether lung function declines over time. We retrospectively assessed lung function at baseline and during follow-up in 96 patients with BHD. Results Ninety-five percent of BHD patients had multiple pulmonary cysts on computed tomography and 59% had experienced at least one pneumothorax. Mean values of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, and total lung capacity were normal at baseline. Mean (standard deviation) residual volume (RV) was moderately increased to 116 (36) %pred at baseline, and RV was elevated > 120%pred in 41% of cases. Mean (standard deviation) carbon monoxide transfer factor (DLco) was moderately decreased to 85 (18) %pred at baseline, and DLco was decreased < 80%pred in 33% of cases. When adjusted for age, gender, smoking and history of pleurodesis, lung function parameters did not significantly decline over a follow-up period of 6 years. Conclusions Cystic lung disease in BHD does not affect respiratory function at baseline except for slightly increased RV and reduced DLco. No significant deterioration of lung function occurs in BHD over a follow-up period of 6 years.http://link.springer.com/article/10.1186/s13023-020-01402-yBirt-Hogg-Dube syndromeFLCN protein, humanRespiratory function testsPleurodesis